Zymeworks 基于CD28共刺激信号的三特异抗体改善肿瘤治疗 TrispecificT Cell Engagers Incorporating Conditional CD28 Co-stimulation (TriTCECo-stim) to Improve Treatment Responses in O.pdf

Zymeworks 基于CD28共刺激信号的三特异抗体改善肿瘤治疗 TrispecificT Cell Engagers Incorporating Conditional CD28 Co-stimulation (TriTCECo-stim) to Improve Treatment Responses in O.pdf

TrispecificTCellEngagersIncorporatingConditional

CD28Co-stimulation(TriTCECo-stim)toImprove

TreatmentResponsesinOncology

PEGSEuropeProteinAntibodyEngineeringSummit

November5,2024

NinaWeisser,PhD

Director,MultispecificAntibodyTherapeutics

Nasdaq:ZYME|

ADC

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档